Empowering Clinical Research Sites And Sponsors In Patient-Centric Era

By KERRY GORMAN, Senior Director, Strategic Site Solutions, COLLEEN GOSA, RNPS Solutions Director, Decentralized Trials, KYLIE SCHEIDELER,Head of Optimization Strategies, Avacare, KATY PRECIADO, Director of DCT Strategy, REBECCA SAYERS, Head of Site Support

Strategic collaboration between clinical trial sites and sponsors plays a critical role in fostering patient-centricity within Decentralized Clinical Trials (DCTs). In an evolving patient-centric model, this partnership alleviates site challenges and ensures sustained patient engagement. Effective patient-centric trials necessitate a site-centric approach, reducing administrative burdens and involving sites in trial design. Successful examples of adaptable, scalable services and collaborative relationships between sponsors and sites demonstrate how in-home protocol requirements and digital engagement tools can improve patient retention and reduce site workload.

Rebecca Sayers from IQVIA envisions the future of clinical trials as a collective business model that bridges gaps between sponsors and sites, utilizing DCT technology platforms like telemedicine and eConsent to enhance efficiency and patient experience. In this paper, experts from IQVIA underscore the necessity of a site-centric approach, positioning research sites as central hubs in patient-centric trials, and ensuring accelerated trial delivery, optimized research, and improved health outcomes to efficiently facilitate the introduction of new medicines to patients.